Welcome to LookChem.com Sign In|Join Free
  • or
N-[(R)-2,3-dihydro-1,4-benzodioxine-2-(R)-ethyl]-2,2,-diphenylacetamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1020746-89-7

Post Buying Request

1020746-89-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1020746-89-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1020746-89-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,2,0,7,4 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1020746-89:
(9*1)+(8*0)+(7*2)+(6*0)+(5*7)+(4*4)+(3*6)+(2*8)+(1*9)=117
117 % 10 = 7
So 1020746-89-7 is a valid CAS Registry Number.

1020746-89-7Upstream product

1020746-89-7Downstream Products

1020746-89-7Relevant academic research and scientific papers

A virtual screen for diverse ligands: Discovery of selective G protein-coupled receptor antagonists

Engel, Stanislav,Skoumbourdis, Amanda P.,Childress, John,Neumann, Susanne,Deschamps, Jeffrey R.,Thomas, Craig J.,Colson, Anny-Odile,Costanzi, Stefano,Gershengorn, Marvin C.

, p. 5115 - 5123 (2008)

Virtual screening has become a major focus of bioactive small molecule lead identification, and reports of agonists and antagonists discovered via virtual methods are becoming more frequent. G protein-coupled receptors (GPCRs) are the one class of protein targets for which success with this approach has been limited. This is likely due to the paucity of detailed experimental information describing GPCR structure and the intrinsic function-associated structural flexibility of GPCRs which present major challenges in the application of receptor-based virtual screening. Here we describe an in silico methodology that diminishes the effects of structural uncertainty, allowing for more inclusive representation of a potential docking interaction with exogenous ligands. Using this approach, we screened one million compounds from a virtual database, and a diverse subgroup of 100 compounds was selected, leading to experimental identification of five structurally diverse antagonists of the thyrotropin-releasing hormone receptors (TRH-R1 and TRH-R2). The chirality of the most potent chemotype was demonstrated to be important in its binding affinity to TRH receptors; the most potent stereoisomer was noted to have a 13-fold selectivity for TRH-R1 over TRH-R2. A comprehensive mutational analysis of key amino acid residues that form the putative binding pocket of TRH receptors further verified the binding modality of these small molecule antagonists. The described virtual screening approach may prove applicable in the search for novel small molecule agonists and antagonists of other GPCRs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1020746-89-7